Home/Filings/4/0001104659-25-006406
4//SEC Filing

Savchuk Nikolay 4

Accession 0001104659-25-006406

CIK 0001130598other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 7:00 PM ET

Size

9.5 KB

Accession

0001104659-25-006406

Insider Transaction Report

Form 4
Period: 2024-12-29
Savchuk Nikolay
DirectorChief Operating Officer10% Owner
Transactions
  • Purchase

    Series A Warrant (right to buy)

    2024-12-29+96,34896,348 total(indirect: By LLC)
    Exercise: $13.42Common Stock (96,348 underlying)
  • Purchase

    Pre-Funded Warrant (right to buy)

    2024-12-29+96,34896,348 total(indirect: By LLC)
    Exercise: $0.01Common Stock (96,348 underlying)
Footnotes (6)
  • [F1]The Pre-Funded Warrants shall become exercisable upon stockholder approval of the exercise of the Pre-Funded Warrants, in accordance with Nasdaq listing rules.
  • [F2]The Pre-Funded Warrants do not expire.
  • [F3]The Pre-Funded Warrants and Series A Warrants were purchased as part of Class B Units, with each Class B Unit consisting of one Pre-Funded Warrant and one Series A Warrant, at a purchase price of $5.093 per Class B Unit.
  • [F4]The Pre-Funded Warrants and Series A Warrants are owned directly by TPAV, LLC, a limited liability company of which the reporting person is the sole manager on its Board of Managers. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F5]The Series A Warrants shall become exercisable on June 30, 2025; provided however, that the Series A Warrants may not be exercised prior to the issuer's receipt of stockholder approval of the exercise of the Series A Warrants, in accordance with Nasdaq listing rules.
  • [F6]The Series A Warrants shall expire on the date that is the earlier of (a) December 31, 2029, and (b) subject to the fulfilment of certain equity conditions, thirty trading days after the last of the following data readouts to occur, as announced by the issuer: (i) Ferret animal model Bird Flu data, (ii) non-human primate Bird Flu data, or (iii) Phase 2a Influenza A human clinical data.

Issuer

Traws Pharma, Inc.

CIK 0001130598

Entity typeother

Related Parties

1
  • filerCIK 0002017800

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 7:00 PM ET
Size
9.5 KB